Race Oncology Ltd (RAC) — Capital Reinvestment Ratio

Latest as of December 2024: 0.00x

Race Oncology Ltd (RAC) has a Capital Reinvestment Ratio of 0.00x as of December 2024, meaning it reinvests 0% of its operating cash flow (AU$570.64K) in capital expenditures (AU$4.00). See RAC equity financing ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

AU$570.64K
AUD

Capital Expenditures

AU$4.00
AUD

Data as of

Dec 2024
Most recent filing

Race Oncology Ltd Capital Reinvestment Ratio (2011–2013)

This chart tracks Race Oncology Ltd's Capital Reinvestment Ratio across 3 annual periods. Check Race Oncology Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Race Oncology Ltd (2011–2013)

Year-by-year Capital Reinvestment Ratio for Race Oncology Ltd from 2011 to 2013. For live market cap and broader valuation context, see RAC company net worth.

Year Reinvestment Ratio Operating CF (AUD) Capital Expenditures YoY Change
2013 0.01x AU$3.71 Million AU$31.00K ▼ -74.4%
2012 0.03x AU$6.68 Million AU$218.00K ▲ +439.7%
2011 0.01x AU$11.92 Million AU$72.00K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow